Stories tagged “pharmaceuticals”, newest first.
Search needs JavaScript. All stories are listed below, newest first.
Shares were up 4.4% pre-market at 07:55 ET (12:55 CET) on 29 October, per Nasdaq, and may still move. Lilly says $4.57 a share of IPR&D charges cut its non-GAAP EPS guide to $35-$36.
Consolidated revenue reached Rs 4,979 crore in the quarter to 30 September 2026. The company says JB businesses added Rs 1,086 crore and that post-merger integration temporarily affected JB revenue.
Global Generics revenues from North America fell 23% to Rs 24,890m while India rose 17% and Emerging Markets 24%. Gross margin narrowed to 52.1% from 54.7%.